ALJAZ Inside Story July 11, 2024
A very crucial age group because vaccines dont tend to work as well in older people because as we get older, our immune systems deteriorate. This vaccine is different from the other 2 that weve been reporting on because it is made from a weakened version of the common cold virus found in chimpanzees, which is then modified to make sure that it cannot grow in humans is given in 2 doses. And so far is reporting and 99 percent efficacy rate. All participants have been gente generating neutralizing antibodies that is knocking out the virus in their bloodstream with no reported side effects. Meanwh...